Protocoled resuscitation and the prevention of acute kidney injury

Current Opinion in Critical Care

Volumn 18, Issue 6, 2012, Pages 613-622

  Brienza, Nicola ^a   Giglio, Maria Teresa ^a   Dalfino, Lidia ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

acute kidney injury; critical illness; hemodynamics; prevention

Indexed keywords

ACICLOVIR; ADRENALIN; AMINOGLYCOSIDE; AMPHOTERICIN B DEOXYCHOLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; COLISTIN; CONTRAST MEDIUM; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; DOPEXAMINE; IMMUNOGLOBULIN; INOTROPIC AGENT; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TACROLIMUS; VANCOMYCIN; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; FLUID RESUSCITATION; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY PERFUSION; NEPHROTOXICITY; REVIEW;

ACUTE KIDNEY INJURY; CARDIOPULMONARY RESUSCITATION; CLINICAL PROTOCOLS; CRITICAL CARE; HEMODYNAMICS; HUMANS; INTENSIVE CARE UNITS;

EID: 84870239952     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32835944d6     Document Type: Review

References (68)

1. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. J Am Med Assoc 2005; 294:813-818. (Pubitemid 41175724)
2. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Complications and costs after high-risk surgery: where should we focus quality improvement initiatives? J Am Coll Surg 2003; 196:671-678. (Pubitemid 36560195)
3. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008; 36:1129-1137. (Pubitemid 351482661)
4. Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009; 249:851-858.
5. Kellum JA. Acute kidney injury. Crit Care Med 2008; 36:S141-S145. (Pubitemid 351483043)
6. Lameire N, Van BW, Vanholder R. Acute kidney injury. Lancet 2008; 372:1863-1865.
7. Zacharias M, Gilmore IC, Herbison GP, et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2005; CD003590.
8. Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit Expert opinion of the working group for nephrology, ESICM. Intensive Care Med 2010; 36:392-411.
9. Brochard L, Abroug F, Brenner M, et al. An Official ATS/ERS/ESICM/SCCM/ SRLF Statement: prevention and management of acute renal failure in the ICU patient. An International Consensus Conference in Intensive Care Medicine. Am J Respir Crit Care Med 2010; 181:1128-1155.
10. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2:1-138.
11. Ostermann M, Dickie H, Barrett NA. Renal replacement therapy in critically ill patients with acute kidney injury: when to start. Nephrol Dial Transplant 2012; 27:2242-2248.
12. Bagshaw SM, Cruz DN, Gibney RTN, Ronco C. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit Care 2009; 13:317.
13. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
14. Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury. A multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57:1752-1761.
15. Doi K, Negishi K, Ishizu T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011; 39:1-6.
16. de Geus H, Bakker J, Lesaffre E, le Noble J. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011; 183:907-914.
17. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-740.
18. Wiedermann CJ, Dunzendorfer S, Gaioni LU, et al. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010; 14:R191.
19. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010; CD007594.
20. Groeneveld AB, Navickis RJ, Wilkse MM. Update onthe comparative safety of colloids: a systematic review of clinical studies. Ann Surg 2011; 253:470-483.
21. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 2012; 114:159-169.
22. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38:368-383.
23. Perner A, Haase N, Guttormsen AB, et al., 6S Trial Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134.
24. Shoemaker WC, Appel PL, Kram HB. Haemodynamic and oxygen transport responses in survivors and nonsurvivors of high-risk surgery. Crit Care Med 1993; 21:977-990. (Pubitemid 23206188)
25. Brienza N, Giglio MT, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009; 37:2079-2090.
26. Berlauk JF, Abrams JH, Gilmour IJ, et al. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery: a prospective, randomized clinical trial. Ann Surg 1991; 214:289-299.
27. Benes J, Chytra I, Altmann P, et al. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care 2010; 14:R118.
28. Bishop MH, Shoemaker WC, Appel PL, et al. Prospective randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma 1995; 38:780-787.
29. Boyd O, Grounds M, Bennett D. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. J Am Med Assoc 1993; 270:2699-2708.
30. Chytra I, Pradl R, Bosman R, et al. Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial. Crit Care 2007; 11:R24.
31. Donati A, Loggi S, Preiser JC, et al. Goal directed intraoperative therapy reduces morbidity and length of hospital stay in high risk surgical patients. Chest 2007; 132:1817-1824.
32. Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002; 97:820-826.
33. Jhanji S, Vivian-Smith A, Lucena-Amaro S, et al. Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial. Crit Care 2010; 14:R151.
34. Lobo SM, Salgado PF, Castillo VG, et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28:3396-3404.
35. Kapoor PM, Kakani M, Chowdhury U, et al. Early goal-directed therapy in moderate to high-risk cardiac surgery patients. Ann Card Anaesth 2008; 11:27-34.
36. Mayer J, Boldt J, Mengistu AM, et al. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care 2010; 14:R18.
37. McKendry M, McGloin H, Saberi D, et al. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. Br Med J 2004; 329:258.
38. Noblett SE, Snowden CP, Shenton BK, Horgan AF. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg 2006; 93:1069-1076. (Pubitemid 44343503)
39. Pearse R, Dawson D, Fawcett J, et al. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay: a randomised, controlled trial. Crit Care 2005; 9:687-693.
40. Polonen P, Ruokonen E, Hippelainen M, et al. A prospective, randomized study of goal oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 2000; 90:1052-1059. (Pubitemid 30253449)
41. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14. (Pubitemid 36026341)
42. Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94:1176-1186. (Pubitemid 19002776)
43. Valentine RJ, Duke ML, Inman MH, et al. Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg 1998; 27:203-212. (Pubitemid 28136801)
44. Wakeling HG, McFall MR, Jenkins CS, et al. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth 2005; 5:634-642. (Pubitemid 41600025)
45. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. Br Med J 1999; 318:1099-1103. (Pubitemid 29192147)
46. Hofer CK, Cecconi M, Marx G, Della Rocca G. Minimally invasive monitoring. Eur J Anaesth 2009; 26:996-1002.
47. Albanese J, Leone M, Garnier F, et al. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004; 126:534-539. (Pubitemid 39093440)
48. Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. SHOCK 2010; 33:375-380.
49. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-887. (Pubitemid 351397087)
50. Redfors B, Bragadottir G, Sellgren J, et al. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011; 37:60-67.
51. Badin J, Boulain T, Ehrmann S, et al. Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort study. Crit Care 2011; 15:R135.
52. Grams ME, Estrella MM, Coresh J, et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6:966-973; 2011.
53. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
54. The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
55. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICESUGAR study data. CMAJ 2009; 180:821-827.
56. Egi M, Bellomo R, Stachowski E, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011; 39:105-111.
57. Dalfino L, Tullo L, Donadio I, et al. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med 2008; 34:707-713. (Pubitemid 351660087)
58. Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol 2011; 22:615-621.
59. De Waele JJ, De Laet I, Kirkpatrick AW, Hoste E. Intra-abdominal hypertension and abdominal compartment syndrome. Am JKidney Dis 2010; 57:159-169.
60. Cheatham ML, Safcsak K. Percutaneous catheter decompression in the treatment of elevated intraabdominal pressure. Chest 2011; 140:1428-1435.
61. Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66:1613-1621. (Pubitemid 39298397)
62. Pagkalis S, Mantadakis E, Mavros MN, et al. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 2011; 71:2277-2294.
63. Cataldo MA, Tacconelli E, Grilli E, et al. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 2012; 67:17-24.
64. Spapen H, Jacobs R, Van Gorp V, et al. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011; 1:14.
65. Perazella MA. Drug use and nephrotoxicity in the intensive care unit. Kidney Int 2012; 81:1172-1178.
66. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med 2008; 36:S216-S223. (Pubitemid 351483055)
67. Hoste EA, Doom S, De Waele J, et al. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 2011; 37:1921-1931.
68. Dalfino L, Puntillo F, Mosca A, et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clin Infect Dis 2012; 54:1720-1726.